
Journal of Diagnostics Concepts & Practice››2024,Vol. 23››Issue (01): 90-95.doi:10.16150/j.1671-2870.2024.01.012
• Review articles •Previous ArticlesNext Articles
YANG Hang, DAI Jing, WANG Xuefeng(
)
Received:2023-05-01Online:2024-02-25Published:2024-05-30Contact:WANG Xuefeng E-mail:wxf10339@rjh.com.cn| [1] | PURCAREA A, SOVAILA S. Sepsis, a 2020 review for the internistJ[J].Rom J Intern Med,2020,58(3):129-137. |
| [2] | SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA,2016,315(8):801-810. doi:10.1001/jama.2016.0287pmid:26903338 |
| [3] | KORHONEN E A, LAMPINEN A, GIRI H, et al. Tie1 controls angiopoietin function in vascular remodeling and inflammation[J].J Clin Invest,2016,126(9):3495-3510. doi:10.1172/JCI84923pmid:27548530 |
| [4] | TEICHERT M, MILDE L, HOLM A, et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation[J].Nat Commun,2017,8:16106. doi:10.1038/ncomms16106pmid:28719590 |
| [5] | BRAUN L J, ZINNHARDT M, VOCKEL M, et al. VE-PTP inhibition stabilizes endothelial junctions by activa-ting FGD5[J].EMBO Rep,2019,20(7):e47046. |
| [6] | LEE S J, LEE C K, KANG S, et al. Angiopoietin-2 exa-cerbates cardiac hypoxia and inflammation after myocardial infarction[J].J Clin Invest,2018,128(11):5018-5033. |
| [7] | SALIMI U, MENDEN H L, MABRY S M, et al. Angiopoie-tin-1 protects against endotoxin-induced neonatal lung injury and alveolar simplification in mice[J].Pediatr Res,2022,91(6):1405-1415. |
| [8] | ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1[J].Crit Care,2023,27(1):250. |
| [9] | YUAN H T, KHANKIN E V, KARUMANCHI S A, et al. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium[J].Mol Cell Biol,2009,29(8):2011-2022. doi:10.1128/MCB.01472-08pmid:19223473 |
| [10] | ZIEGLER T, HORSTKOTTE J, SCHWAB C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis.J Clin Invest,2013,123(8):3436-3445. |
| [11] | RICHTER R P, ASHTEKAR A R, ZHENG L, et al. Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress-related AMPK/FoxO1 signaling[J].JCI Insight,2022,7(15):e155010. |
| [12] | LUKASZ A, HILLGRUBER C, OBERLEITHNER H, et al. Endothelial glycocalyx breakdown is mediated by angiopoietin-2[J].Cardiovasc Res,2017,113(6):671-680. doi:10.1093/cvr/cvx023pmid:28453727 |
| [13] | DROST C C, ROVAS A, KUSCHE-VIHROG K, et al. Tie2 activation promotes protection and reconstitution of the endothelial glycocalyx in human sepsis[J].Thromb Haemost,2019,119(11):1827-1838. |
| [14] | 付绪哲, 柳英杰, 牛明明, 等. 脓毒症免疫抑制机制的研究进展[J].中国临床研究,2023,36(5):741-745. |
| FU X Z, LIU Y J, NIU M M, et al. Research progress in immunosuppressive mechanism of sepsis[J].Chin J Clin Res,2023,36(5):741-745. | |
| [15] | SMADJA D M, GUERIN C L, CHOCRON R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients[J].Angiogenesis,2020,23(4):611-620. doi:10.1007/s10456-020-09730-0pmid:32458111 |
| [16] | FIEDLER U, REISS Y, SCHARPFENECKER M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation[J].Nat Med,2006,12(2):235-239. doi:10.1038/nm1351pmid:16462802 |
| [17] | LASK A, GUTBIER B, KERSHAW O, et al. Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice[J].Sci Rep,2022,12(1):15531. doi:10.1038/s41598-022-19560-3pmid:36109537 |
| [18] | IDOWU T O, ETZRODT V, SEELIGER B, et al. Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis[J].Elife,2020,9:e59520. |
| [19] | 闫威威, 董思琴, 汪华学. 红细胞分布宽度与血小板计数比值对脓毒症患者预后的预测价值[J].安徽医学,2022,43(8):887-891. |
| YAN W W, DONG S Q, WANG H X. The predictive value of the ratio of red blood cell distribution width to platelet count for the prognosis of sepsis patients[J].Anhui Med J,2022,43(8):887-891. | |
| [20] | HIGGINS S J, DE CEUNYNCK K, KELLUM J A, et al. Tie2 protects the vasculature against thrombus formation in systemic inflammation[J].J Clin Invest,2018,128(4):1471-1484. doi:10.1172/JCI97488pmid:29360642 |
| [21] | SCHMAIER A A, PAJARES HURTADO G M, MANICKAS-HILL Z J, et al. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19[J].JCI Insight,2021,6(20):e151527. |
| [22] | SZEDERJESI J, ALMASY E, LAZAR A, et al. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis[J].J Crit Care Med (Targu Mures),2015,1(1):18-23. |
| [23] | CALFEE C S, JANZ D R, BERNARD G R, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies[J].Chest,2015,147(6):1539-1548. doi:S0012-3692(15)37209-3pmid:26033126 |
| [24] | RICHTER R P, ZHENG L, ASHTEKAR A R, et al. Associations of Plasma Angiopoietins-1 and -2 and Angiopoie-tin-2/-1 Ratios With Measures of Organ Injury and Clinical Outcomes in Children With Sepsis: A Preliminary Report[J].Pediatr Crit Care Med,2020,21(9):e874-e878. |
| [25] | PRICE D R, BENEDETTI E, HOFFMAN K L, et al. Angiopoietin 2 is associated with vascular necroptosis induction in coronavirus disease 2019 acute respiratory distress syndrome[J].Am J Pathol,2022,192(7):1001-1015. |
| [26] | REILLY J P, WANG F, JONES T K, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-asso-ciated ARDS development: evidence from Mendelian randomization and mediation analysis[J].Intensive Care Med,2018,44(11):1849-1858. |
| [27] | ROSENBERGER C M, WICK K D, ZHUO H, et al. Early plasma angiopoietin-2 is prognostic for ARDS and morta-lity among critically ill patients with sepsis[J].Crit Care,2023,27(1):234. |
| [28] | YU W K, MCNEIL J B, WICKERSHAM N E, et al. Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure[J].Crit Care,2021,25(1):48. |
| [29] | ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock[J].Crit Care,2023,27(1):260. |
| [30] | FANG Y, LI C, SHAO R, et al. The role of biomarkers of endothelial activation in predicting morbidity and morta-lity in patients with severe sepsis and septic shock in intensive care: A prospective observational study[J].Thromb Res,2018,171:149-154. |
| [31] | KIM W Y, KWEON O J, CHA M J, et al. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study[J].PLoS One,2021,16(7):e0254167. |
| [32] | KNAUP H, STAHL K, SCHMIDT B M W, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers[J].Crit Care,2018,22(1):285. |
| [33] | HOFMAENNER D A, DAVID S. From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDS[J].Crit Care,2023,27(1):183. |
| [34] | JIANG S, LI S, HU J, et al. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy[J].Nanomedicine,2019,15(1):25-36. doi:S1549-9634(18)30513-6pmid:30193816 |
| [35] | JONES R S, SMITH P S, BERG P H, et al. Efficacy and safety of LY3127804, an anti-angiopoietin-2 antibody, in a randomized, double-blind, placebo-controlled clinical trial in patients hospitalized with pneumonia and presumed or confirmed COVID-19[J].Clin Med Insights Circ Respir Pulm Med,2022,16:11795484221119316. |
| [1] | WANG Qiuyun, CHEN Ying, ZHAO Bing, SUN Silei, YANG Zhitao, MAO Enqiang, CHEN Erzhen.Sirt1 involved in sepsis-induced acute liver injuryviaregulating HNF-1α/FXR-1 pathway: The mechanism study in a rodent model[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 279-285. |
| [2] | .[J]. Journal of Diagnostics Concepts & Practice, 2015, 14(04): 363-366. |
| [3] | .[J]. Journal of Diagnostics Concepts & Practice, 2010, 9(01): 58-62. |
| [4] | .[J]. Journal of Diagnostics Concepts & Practice, 2009, 8(05): 484-486. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||